Keyence Corporation (OTCMKTS:KYCCF – Free Report) – Investment analysts at Erste Group Bank upped their FY2027 earnings estimates for shares of Keyence in a research note issued on Thursday, August 27th. Erste Group Bank analyst H. Engel now anticipates that the company will post earnings of $14.67 per share for the year, up from their prior estimate of $14.41. Erste Group Bank currently has a “Strong-Buy” rating on the stock. The consensus estimate for Keyence’s current full-year earnings is $14.67 per share. Erste Group Bank also issued estimates for Keyence’s FY2028 earnings at $16.23 EPS.
KYCCF has been the subject of several other research reports. Zacks Research raised Keyence to a “hold” rating in a research note on Tuesday, May 19th. The Goldman Sachs Group upgraded Keyence from a “hold” rating to a “buy” rating in a research report on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Buy”.
Keyence Price Performance
KYCCF opened at $506.00 on Monday. The business’s fifty day simple moving average is $498.81 and its 200 day simple moving average is $453.39. Keyence has a 52 week low of $316.20 and a 52 week high of $581.60.
About Keyence
Keyence Corporation, established in 1974 by Takemitsu Takizaki and headquartered in Osaka, Japan, is a leading developer and manufacturer of automation and inspection equipment. The company focuses on delivering advanced technologies that improve manufacturing efficiency and quality control for a broad range of industries, including automotive, electronics, pharmaceuticals, food and beverage, and packaging.
Keyence’s product portfolio encompasses a variety of sensors, vision systems, laser markers, digital microscopes and measuring instruments.
Featured Articles
- Five stocks we like better than Keyence
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Keyence Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keyence and related companies with MarketBeat.com's FREE daily email newsletter.
